September 4, 2025 · Form 4 insider transaction
Stapley Marc sold 7,667 shares of Veracyte, Inc. at $30.41 per share, a transaction worth $233.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 13, 2024.; Represents weighted average sales price. Sale prices for the transactions range from $30.22 to $30.66. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.